Showing results (1611-1620 of 1,868) with videos related to

Sort By:
Pageof 187
Blood|October 25, 2011
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysisGareth J Morgan, Walter M Gregory, Faith E Davies, et al.
Investigational New Drugs|April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
JTO Clinical and Research Reports|January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS MutationsKathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
American Journal of Infection Control|February 14, 2012
"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosaDror Marchaim, Federico Perez, Jiha Lee, et al.
Nature Medicine|February 12, 2020
Regenerative lineages and immune-mediated pruning in lung cancer metastasisAshley M Laughney, Jing Hu, Nathaniel R Campbell, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritisYibo He, Outi Sareila, Linda Johansson, et al.
Arthritis Research & Therapy|June 22, 2023
Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosusAgnes Torell, Marit Stockfelt, Gunilla Larsson, et al.
Haematologica|November 8, 2011
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial resultsGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumanniiMaria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.
Pageof 187